{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:15:27Z","timestamp":1788545727758,"version":"build-2803163510"},"reference-count":144,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"state assignments","award":["124020500028-4"],"award-info":[{"award-number":["124020500028-4"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxics"],"abstract":"<jats:p>Meloxicam, a selective cyclooxygenase-2 inhibitor, is commonly used as non-steroidal anti-inflammatory drug in both human and veterinary medicine. Owing to its heterocyclic structure, toxicity to invertebrates, vertebrates, and microorganisms, and potential to biomagnify through the food webs, meloxicam persists in the environment and poses a risk to ecological health. There is still a paucity of information on meloxicam as a pharmaceutical contaminant. It is not included in priority lists, which means its environmental risk is often underestimated. This paper provides an integrative overview of the currently available literature (2009\u20132026) on the environmental occurrences, ecotoxicity, transport pathways, and removal strategies of meloxicam. The distribution of meloxicam has been most extensively studied in aquatic environments, whereas information on soils, plants, and terrestrial fauna remains limited. Bioaugmentation is the most promising strategy for reducing ecotoxicological risk, although its effectiveness against meloxicam has so far been confirmed only in a few model systems. The evidence presented here underscores the importance of strict regulation of meloxicam use and routine environmental monitoring. We hope this review will be useful to ecologists, microbiologists, and regulatory agencies developing strategies to mitigate pharmaceutical contamination.<\/jats:p>","DOI":"10.3390\/toxics14070631","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:18:31Z","timestamp":1784553511000},"page":"631","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Meloxicam in the Environment: Pathways of Entry, Ecotoxicity, and Removal Strategies"],"prefix":"10.3390","volume":"14","author":[{"given":"Semyon M.","family":"Tyan","sequence":"first","affiliation":[{"name":"Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences, Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, 13 Golev Str., 614081 Perm, Russia"},{"name":"Department of Microbiology and Immunology, Perm State National Research University, 15 Bukirev Str., 614990 Perm, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2558-4789","authenticated-orcid":false,"given":"Irina B.","family":"Ivshina","sequence":"additional","affiliation":[{"name":"Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences, Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, 13 Golev Str., 614081 Perm, Russia"},{"name":"Department of Microbiology and Immunology, Perm State National Research University, 15 Bukirev Str., 614990 Perm, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/etc.5827","article-title":"Pharmaceuticals and personal care products in the environment: What progress has been made in addressing the big research questions?","volume":"43","author":"Boxall","year":"2024","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Heredia, C., Workentin, A., Parker, G., and Persaud, N. (2025). The potential role of ecotoxicological data in National Essential Medicine Lists: A cross-sectional analysis. Int. J. Environ. Res. Public Health, 22.","DOI":"10.3390\/ijerph22040632"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1134\/S1067413625600910","article-title":"Pharmaceuticals in the environment: Current state of research and overcoming collective problems","volume":"56","author":"Ivshina","year":"2025","journal-title":"Russ. J. Ecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101404","DOI":"10.1016\/j.lanplh.2025.101404","article-title":"Pharmaceutical pollution from health care: A systems-based strategy for mitigating risks to public and environmental health","volume":"10","author":"Thornber","year":"2026","journal-title":"Lancet Planet. Health"},{"key":"ref_5","unstructured":"OECD (2019). Defining the challenge of managing pharmaceuticals in water. Pharmaceutical Residues in Freshwater: Hazards and Policy Responses, OECD. OECD Studies on Water OECD Studies on Water."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Parker, G., and Miller, F.A. (2024). Tackling pharmaceutical pollution along the product lifecycle: Roles and responsibilities for producers, regulators and prescribers. Pharmacy, 12.","DOI":"10.3390\/pharmacy12060173"},{"key":"ref_7","first-page":"e27","article-title":"Cardiovascular implications of non-steroidal anti-inflammatory drugs: A comprehensive review, with emphasis on patients with rheumatoid arthritis","volume":"19","author":"Ikdahl","year":"2024","journal-title":"Pharmacotherapy"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hessami, A., Pourali, A., Saeedi, M., Asghar, A., Ghara, N., Kheradmand, M., and Moosazadeh, M. (2025). A study of demographic and clinical characteristics of consumers of non-steroidal anti-inflammatory drugs: A large population-based study utilizing enrollment phase data from the tabari cohort. BMC Public Health, 25.","DOI":"10.1186\/s12889-025-24005-3"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Wu, X., Chen, X., Gao, F., and Wang, J. (2025). Global and regional burden, temporal trends, and projections of chronic pain from 1990 to 2032, and its association with cardiovascular diseases: Analyses based on global burden of diseases study 2021. Front. Public Health, 13.","DOI":"10.3389\/fpubh.2025.1636949"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1073\/pnas.1503141112","article-title":"Global trends in antimicrobial use in food animals","volume":"112","author":"Brower","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","unstructured":"NHS Sustainable Development Unit (2018). Reducing the Use of Natural Resources in Health and Social Care, NHS Sustainable Development Unit."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"McGettigan, P., and Henry, D. (2013). Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: An examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med., 10.","DOI":"10.1371\/journal.pmed.1001388"},{"key":"ref_13","first-page":"823","article-title":"Pharmaceuticals in the environment\u2014Global occurrences and perspective","volume":"35","author":"Weber","year":"2016","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"166897","DOI":"10.1016\/j.scitotenv.2023.166897","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) in the environment: Recent updates on the occurrence, fate, hazards and removal technologies","volume":"904","author":"Lin","year":"2023","journal-title":"Sci. Total Environ."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101775","DOI":"10.1016\/j.toxrep.2024.101775","article-title":"From prescription to pollution: The ecological consequences of NSAIDs in aquatic ecosystems","volume":"13","author":"Lakshmi","year":"2024","journal-title":"Toxicol. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/etc.5763","article-title":"Pharmaceuticals and personal care products in the aquatic environment: How can regions at risk be identified in the future?","volume":"43","author":"Wilkinson","year":"2024","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_17","unstructured":"Bethesda, M. (2026, May 26). LiverTox\u00ae: Clinical and Research Information on Drug-Induced Liver Injury [Meloxicam], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"de la Puente, R., Diez, R., Diez, M.J., Fernandez, N., Sahagun, A.M., Rodriguez, J.M., Garcia, J.J., and Lopez, C. (2024). Pharmacokinetics of meloxicam in different animal species: A comprehensive review. Vet. Sci., 11.","DOI":"10.3390\/vetsci11110519"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ort\u00fazar, M., Esterhuizen, M., Olic\u00f3n-Hern\u00e1ndez, D.R., Gonz\u00e1lez-L\u00f3pez, J., and Aranda, E. (2022). Pharmaceutical pollution in aquatic environments: A concise review of environmental impacts and bioremediation systems. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.869332"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"106007","DOI":"10.1016\/j.ibiod.2025.106007","article-title":"Luffa cylindrica-based immobilization: Effects on metabolic activity and paracetamol degradation by Pseudomonas moorei KB4","volume":"198","author":"Guzik","year":"2025","journal-title":"Int. Biodeterior. Biodegrad."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"118618","DOI":"10.1016\/j.ecoenv.2025.118618","article-title":"Diclofenac (DCF) as an emerging pollutant: Occurrence, ecotoxicity, and biodegradation strategies","volume":"302","author":"Badawy","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"164600","DOI":"10.1016\/j.scitotenv.2023.164600","article-title":"Occurrence, removal and risk evaluation of ibuprofen and acetaminophen in municipal wastewater treatment plants: A critical review","volume":"891","author":"Wu","year":"2023","journal-title":"Sci. Total Environ."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00253-019-10343-x","article-title":"Naproxen in the environment: Its occurrence, toxicity to nontarget organisms and biodegradation","volume":"104","author":"Guzik","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3390\/jox14040082","article-title":"Pharmaceutical pollutants: Ecotoxicological impacts and the use of agro-industrial waste for their removal from aquatic environments","volume":"14","year":"2024","journal-title":"Xenobiotics"},{"key":"ref_25","first-page":"e56","article-title":"Analgesic efficacy of meloxicam vs ibuprofen on pain after third molar surgery in adult patients. A randomized controlled clinical trial","volume":"31","author":"Aguilera","year":"2026","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jcph.1058","article-title":"A randomized double-blind controlled trial of intravenous meloxicam in the treatment of pain following dental impaction surgery","volume":"58","author":"Christensen","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4103\/joacp.JOACP_133_18","article-title":"Meloxicam in the management of post-operative pain: Narrative review","volume":"34","author":"Bekker","year":"2018","journal-title":"J. Anaesthesiol. Clin. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2217\/pmt-2020-0082","article-title":"Meloxicam for intravenous use: Review of its clinical efficacy and safety for management of postoperative pain","volume":"11","author":"Berkowitz","year":"2020","journal-title":"Pain Manag."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Carter, J.A., Black, L.K., Sharma, D., Bhagnani, T., and Jahr, J.S. (2020). Efficacy of non-opioid analgesics to control postoperative pain: A network meta-analysis. BMC Anesthesiol., 20.","DOI":"10.1186\/s12871-020-01147-y"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jfms.2007.10.007","article-title":"Long-term safety, efficacy and palatability of oral meloxicam at 0.01\u20130.03 mg\/kg for treatment of osteoarthritic pain in cats","volume":"10","author":"Gunew","year":"2008","journal-title":"J. Feline Med. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-\u00c1valos, I., Valverde, A., Ibancovichi-Camarillo, J., S\u00e1nchez-Aparicio, P., Recillas-Morales, S., Osorio-Avalos, J., Rodr\u00edguez-Vel\u00e1zquez, D., and Miranda-Cort\u00e9s, A.E. (2020). Clinical evaluation of postoperative analgesia, cardiorespiratory parameters and changes in liver and renal function tests of paracetamol compared to meloxicam and carprofen in dogs undergoing ovariohysterectomy. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0223697"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/jvim.17136","article-title":"Comparison of grapiprant and meloxicam for management of postoperative joint pain in dogs: A randomized, double-blinded, prospective clinical trial","volume":"38","author":"Cassemiche","year":"2024","journal-title":"J. Vet. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Dzi\u0119cio\u0142, M., Szpaczek, A., Ucha\u0144ska, O., and Ni\u017ca\u0144ski, W. (2022). Influence of a single dose of meloxicam administrated during canine estrus on progesterone concentration and fertility\u2014A clinical case study. Animals, 12.","DOI":"10.3390\/ani12050655"},{"key":"ref_34","unstructured":"Research Nester (2026, May 29). Meloxicam Market. Available online: https:\/\/www.researchnester.com\/ru\/reports\/meloxicam-market\/5360."},{"key":"ref_35","first-page":"100850","article-title":"A decade of water monitoring in a Mediterranean region: Pharmaceutical prioritisation for an upgraded analytical methodology","volume":"20","author":"Buttiglieri","year":"2023","journal-title":"Environ. Nanotechnol. Monit. Manag."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0928-0987(95)00046-1","article-title":"Structure and physicochemical properties of meloxicam, a new NSAID","volume":"4","author":"Luger","year":"1996","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Friuli, V., Urru, C., Ferrara, C., Conti, D.M., Bruni, G., Maggi, L., and Capsoni, D. (2024). Design of etched- and functionalized-halloysite\/meloxicam hybrids: A tool for enhancing drug solubility and dissolution rate. Pharmaceuticals, 16.","DOI":"10.3390\/pharmaceutics16030338"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1021\/es0484146","article-title":"Environmental fate of pharmaceuticals in water\/sediment systems","volume":"39","author":"Meller","year":"2005","journal-title":"Environ. Sci. Technol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"37988","DOI":"10.1021\/acsomega.2c05189","article-title":"Effect of N-methyl-pyrrolidone (NMP) on the equilibrium solubility of meloxicam in aqueous media: Correlation, dissolution thermodynamics, and preferential solvation","volume":"7","author":"Almanza","year":"2022","journal-title":"ACS Omega"},{"key":"ref_40","unstructured":"(2026, February 02). DrugBank. DrugBank Online. Available online: https:\/\/go.drugbank.com\/."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1021\/acs.cgd.5c01574","article-title":"Multicomponent oxicam-metformin salts: Toward a strategy for enhancing solubility and stability","volume":"26","author":"Frontera","year":"2026","journal-title":"Cryst. Growth Des."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejps.2017.08.029","article-title":"Analysis of polymorphic contamination in meloxicam raw materials and its effects on the physicochemical quality of drug product","volume":"109","author":"Freitas","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Braga, D., Casali, L., and Grepioni, F. (2022). The relevance of crystal forms in the pharmaceutical field: Sword of damocles or innovation tools?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169013"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Z\u00e1mostn\u00fd, P., Drahozal, M., \u0160vehla, O., R\u00f6merov\u00e1, S., and Marinko, N. (2023). Drug release from carrier systems comprising meloxicam crystals formed by impregnation-evaporation. Crystals, 13.","DOI":"10.3390\/cryst13030527"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"107575","DOI":"10.1016\/j.microc.2022.107575","article-title":"A comparative approach of MIR, NIR and Raman based chemometric strategies for quantification of form I of meloxicam in commercial bulk drug","volume":"180","author":"Antonio","year":"2022","journal-title":"Microchem. J."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Maggi, L., Friuli, V., Cerea, B., Bruni, G., Berbenni, V., and Bini, M. (2024). Physicochemical characterization of hydroxyapatite hybrids with meloxicam for dissolution rate improvement. Molecules, 29.","DOI":"10.3390\/molecules29112419"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/jps.22434","article-title":"Coformer selection in pharmaceutical cocrystal development: A case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics","volume":"100","author":"Cheney","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1021\/acs.molpharmaceut.6b00613","article-title":"Investigation and mathematical description of the real driving force of passive transport of drug molecules from supersaturated solutions","volume":"13","author":"Tsinman","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Macasoi, C., Meltzer, V., Stanculescu, I., Romanitan, C., and Pincu, E. (2024). Binary mixtures of meloxicam and L-tartaric acid for oral bioavailability modulation of pharmaceutical dosage forms. J. Funct. Biomater., 15.","DOI":"10.3390\/jfb15040104"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0049-0172(97)80049-2","article-title":"Meloxicam: Selective COX-2 inhibition in clinical practice","volume":"26","author":"Furst","year":"1997","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40545-021-00325-8","article-title":"National drug utilization trend of analgesics in China: An analysis of procurement data at 793 public hospitals from 2013 to 2018","volume":"14","author":"Shi","year":"2021","journal-title":"J. Pharm. Policy Pract."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/cpdd.965","article-title":"Pharmacokinetics of meloxicam tablets in healthy chinese adults in the fasting and fed states: A single-site, single-dose, randomized, open, 2-period, 2-sequence, crossover bioequivalence study","volume":"11","author":"Yu","year":"2022","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Veronese, N., Ecarnot, F., Cheleschi, S., Fioravanti, A., and Maggi, S. (2022). Possible synergic action of non-steroidal anti-inflammatory drugs and glucosamine sulfate for the treatment of knee osteoarthritis: A scoping review. BMC Musculoskelet. Disord., 23.","DOI":"10.1186\/s12891-022-06046-6"},{"key":"ref_54","first-page":"1","article-title":"Metabolism of meloxicam in human liver involves cytochromes P4502C9 and 3A4","volume":"28","author":"Guyomard","year":"1998","journal-title":"Xenobiotica"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.47360\/1995-4484-2021-302-315","article-title":"An old friend: 25 years of meloxicam use in Russia","volume":"59","author":"Karateev","year":"2021","journal-title":"Rheumatol. Sci. Pract."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1007\/s00296-017-3835-x","article-title":"Meloxicam and risk of myocardial infarction: A population-based nested case-control study","volume":"37","author":"Dalal","year":"2017","journal-title":"Rheumatol. Int."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Cheng, L., Hu, Z., Gu, J., Li, Q., Liu, J., Liu, M., Li, J., and Bi, X. (2024). Exploring COX-independent pathways: A novel approach for meloxicam and other NSAIDs in cancer and cardiovascular disease treatment. Pharmaceuticals, 17.","DOI":"10.3390\/ph17111488"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta12110","article-title":"Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: A systematic review and economic evaluation","volume":"12","author":"Chen","year":"2008","journal-title":"Health Technol. Assess."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"127458","DOI":"10.1016\/j.seppur.2024.127458","article-title":"Pharmaceuticals wastewater treatment via different advanced oxidation processes: Reaction mechanism, operational factors, toxicities, and cost evaluation\u2014A review","volume":"347","author":"Iqbal","year":"2024","journal-title":"Sep. Purif. Technol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1021\/acs.chemrev.8b00299","article-title":"Pharmaceuticals of emerging concern in aquatic systems: Chemistry, occurrence, effects, and removal methods","volume":"119","author":"Patel","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"149412","DOI":"10.1016\/j.scitotenv.2021.149412","article-title":"Drug pollution & Sustainable Development Goals","volume":"800","author":"Orive","year":"2021","journal-title":"Sci. Total Environ."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1016\/S2542-5196(22)00090-0","article-title":"Review pollution and health: A progress update","volume":"6","author":"Fuller","year":"2022","journal-title":"Lancet Planet. Health"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.1021\/acs.inorgchem.3c04080","article-title":"A 20-metal Zn(II)-Cd(II)-Eu(III) nanocluster with qualitative and quantitative luminescence detection of meloxicam (an anti-inflammatory drug)","volume":"63","author":"Lin","year":"2024","journal-title":"Inorg. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2166\/wst.2021.025","article-title":"Degradation of the mixture of the ketoprofen, meloxicam and tenoxicam drugs using TiO2\/metal photocatalysers supported in polystyrene packaging waste","volume":"83","author":"Lima","year":"2021","journal-title":"Water Sci. Technol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"160031","DOI":"10.1016\/j.scitotenv.2022.160031","article-title":"Current research trends on emerging contaminants pharmaceutical and personal care products (PPCPs): A comprehensive review","volume":"859","author":"Kumar","year":"2023","journal-title":"Sci. Total Environ."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/cobi.12417","article-title":"Suspected flunixin poisoning of a wild Eurasian Griffon Vulture from Spain","volume":"29","author":"Zorrilla","year":"2015","journal-title":"Conserv. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"115157","DOI":"10.1016\/j.envpol.2020.115157","article-title":"NSAIDs detected in Iberian avian scavengers and carrion after diclofenac registration for veterinary use in Spain","volume":"266","author":"Velarde","year":"2020","journal-title":"Environ. Pollut."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.chemosphere.2017.12.020","article-title":"Targeted eco-pharmacovigilance for ketoprofen in the environment: Need, strategy and challenge","volume":"194","author":"Wang","year":"2018","journal-title":"Chemosphere"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"134815","DOI":"10.1016\/j.scitotenv.2019.134815","article-title":"Comparison of the regulatory outline of ecopharmacovigilance of pharmaceuticals in Europe, USA, Japan and Australia","volume":"709","author":"Jose","year":"2020","journal-title":"Sci. Total Environ."},{"key":"ref_70","unstructured":"United Nations (2020). World Water Development Report 2020: Water and Climate Change, UNESCO."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Varatharajan, G.R., Ndayishimiye, J.C., and Nyirabuhoro, P. (2025). Emerging contaminants: A rising threat to urban water and a barrier to achieving SDG-aligned planetary protection. Water, 17.","DOI":"10.3390\/w17162367"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.scitotenv.2019.03.372","article-title":"Comparison of regulatory frameworks of environmental risk assessments for human pharmaceuticals in EU, USA, and Canada","volume":"671","author":"Lee","year":"2019","journal-title":"Sci. Total Environ."},{"key":"ref_73","unstructured":"U.S. Environmental Protection Agency (2026, June 01). CompTox Chemicals Dashboard, Available online: https:\/\/comptox.epa.gov\/dashboard."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.chemosphere.2017.10.056","article-title":"Forced and long-term degradation assays of tenoxicam, piroxicam and meloxicam in river water. Degradation products and adsorption to sediment","volume":"191","author":"Pardo","year":"2018","journal-title":"Chemosphere"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Tyan, S., Kostrikina, N., Sorokin, V., Mulyukin, A., and Ivshina, I. (2025). Adaptive responses of Gordonia alkanivorans IEGM 1277 to the action of meloxicam and its efficient biodegradation. Front. Bioeng. Biotechnol., 13.","DOI":"10.3389\/fbioe.2025.1603975"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Alabbas, A.B., and Abdel-Gawad, S.A. (2026). Environmental monitoring of celecoxib, ketoprofen, and meloxicam in pharmaceutical wastewater by SPE-assisted micellar electrokinetic chromatography. Chemosensors, 14.","DOI":"10.3390\/chemosensors14030069"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.talanta.2014.11.022","article-title":"Green analytical determination of emerging pollutants in environmental waters using excitation\u2013emission photoinduced fluorescence data and multivariate calibration","volume":"134","author":"Lozano","year":"2015","journal-title":"Talanta"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.21577\/1984-6835.20190094","article-title":"A solid phase pre-concentration study concerning lornoxicam: A likely future emerging pollutant","volume":"11","author":"Cabral","year":"2019","journal-title":"Rev. Virtual Quim."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0378-4347(99)00537-X","article-title":"Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples","volume":"738","author":"Velpandian","year":"2000","journal-title":"J. Chromatogr. B"},{"key":"ref_80","first-page":"248","article-title":"UV-spectrophotometric determination of the active pharmaceutical ingredients meloxicam and nimesulide in cleaning validation samples with sodium carbonate","volume":"6","author":"Nikolaychuk","year":"2023","journal-title":"J"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"110491","DOI":"10.1016\/j.foodcont.2024.110491","article-title":"Detection of meloxicam residues in milk using ATR-FTIR spectroscopy coupled with chemometrics","volume":"163","author":"Saji","year":"2024","journal-title":"Food Control"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"32537","DOI":"10.1038\/s41598-025-18548-z","article-title":"FDA validated ecofriendly HPTLC method for quantification of florfenicol and meloxicam in bovine tissues with sustainability assessment","volume":"15","author":"Sharkawi","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Alqarni, A.M. (2024). Analytical methods for the determination of pharmaceuticals and personal care products in solid and liquid environmental matrices: A review. Molecules, 29.","DOI":"10.3390\/molecules29163900"},{"key":"ref_84","first-page":"99","article-title":"Regulations and treatment strategies for pharmaceutical wastewater\u2014A review","volume":"36","author":"Khan","year":"2025","journal-title":"Ecol. Quest."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"118049","DOI":"10.1016\/j.envpol.2021.118049","article-title":"Aquatic concentration and risk assessment of pharmaceutically active compounds in the environment","volume":"290","author":"Santos","year":"2021","journal-title":"Environ. Pollut."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Papaioannou, C., Geladakis, G., Kommata, V., Batargias, C., and Lagoumintzis, G. (2023). Insights in pharmaceutical pollution: The prospective role of eDNA metabarcoding. Toxics, 11.","DOI":"10.3390\/toxics11110903"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"165323","DOI":"10.1016\/j.scitotenv.2023.165323","article-title":"Occurrence, fate, and potential risk of pharmaceutical pollutants in agriculture: Challenges and environmentally friendly solutions","volume":"899","author":"Nguyen","year":"2023","journal-title":"Sci. Total Environ."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"116446","DOI":"10.1016\/j.watres.2020.116446","article-title":"A review of the biotransformations of priority pharmaceuticals in biological wastewater treatment processes","volume":"188","author":"Nguyen","year":"2021","journal-title":"Water Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.chroma.2012.05.084","article-title":"Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem","volume":"1248","author":"Gros","year":"2012","journal-title":"J. Chromatogr. A"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"131226","DOI":"10.1016\/j.jclepro.2022.131226","article-title":"Overview of non-steroidal anti-inflammatory drugs degradation by advanced oxidation processes","volume":"346","author":"Vieira","year":"2022","journal-title":"J. Clean. Prod."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1007\/s00216-015-8654-x","article-title":"Multianalyte method for the determination of pharmaceuticals in wastewater samples using solid-phase extraction and liquid chromatography\u2013tandem mass spectrometry","volume":"407","author":"Dasenaki","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1039\/C4AY01200C","article-title":"LC-QTOF-MS method for the analysis of residual pharmaceuticals in wastewater: Application to a comparative multiresidue trace analysis between spring and winter water","volume":"6","author":"Zhao","year":"2014","journal-title":"Anal. Methods"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Schoos, A., Chantziaras, I., Vandenabeele, J., Biebaut, E., Meyer, E., Cools, A., Devreese, M., and Maes, D. (2020). Prophylactic use of meloxicam and paracetamol in peripartal sows suffering from postpartum dysgalactia syndrome. Front. Vet. Sci., 7.","DOI":"10.3389\/fvets.2020.603719"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/jpbs.jpbs_649_21","article-title":"Meloxicam in combating clinical mastitis: Nanotechnology-driven hope and opportunities","volume":"14","author":"Jyothi","year":"2022","journal-title":"J. Pharm. Bioallied Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1292\/jvms.23-0424","article-title":"Effect of 2% meloxicam injection in Holstein dairy cows on acute clinical mastitis without systemic symptoms","volume":"86","author":"Hisaeda","year":"2024","journal-title":"J. Vet. Med. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3168\/jds.2020-19500","article-title":"Ultrasensitive and simultaneous detection of 6 nonsteroidal anti-inflammatory drugs by colloidal gold strip sensor","volume":"104","author":"Lin","year":"2021","journal-title":"J. Dairy Sci."},{"key":"ref_97","first-page":"15","article-title":"Case study: Detection of two nonsteroidal anti-inflammatory drugs (NSAIDs) in the eggs of captive-reared bearded vultures at a breeding center in southern Spain","volume":"38","author":"Zorrilla","year":"2018","journal-title":"J. Wildl. Rehabil."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.vaa.2023.09.072","article-title":"Pharmacokinetics of the analgesic and anti-inflammatory drug meloxicam after administration of multiple doses to nursehound sharks (Scyliorhinus stellaris)","volume":"51","author":"Encinas","year":"2024","journal-title":"Vet. Anaesth. Analg."},{"key":"#cr-split#-ref_99.1","unstructured":"Commission (2018). Commission Implementing Regulation"},{"key":"#cr-split#-ref_99.2","unstructured":"(EU) 2018\/837 of 31 May 2018 concerning the classification of certain goods in the Combined Nomenclature. Off. J. Eur. Union, L142, 3-5."},{"key":"#cr-split#-ref_100.1","unstructured":"Commission (2025). Commission Implementing Decision"},{"key":"#cr-split#-ref_100.2","unstructured":"(EU) 2025\/439 of 28 February 2025 establishing a watch list of substances for union-wide monitoring in the field of water policy pursuant to Directive 2008\/105\/EC of the European Parliament and of the Council, Notified under document C(2025) 1244. Off. J. Eur. Union, L62, 15-19."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"120170","DOI":"10.1016\/j.jenvman.2024.120170","article-title":"Advanced oxidation and biological integrated processes for pharmaceutical wastewater treatment: A review","volume":"353","author":"Adeoye","year":"2024","journal-title":"J. Environ. Manag."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/vms3.1207","article-title":"Toxicological effects of meloxicam on physiological and antioxidant status of common carp (Cyprinus carpio)","volume":"9","author":"Sheikhlangi","year":"2023","journal-title":"Vet. Med. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"117233","DOI":"10.1016\/j.watres.2021.117233","article-title":"Dawning of a new ERA: Environmental risk assessment of antibiotics and their potential to select for antimicrobial resistance","volume":"200","author":"Murray","year":"2021","journal-title":"Water Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/etc.5702","article-title":"Predicting environmental risks of pharmaceuticals from wholesale data: An example from Norway","volume":"42","author":"Welch","year":"2023","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.yrtph.2014.04.006","article-title":"Ecological risk assessment of the presence of pharmaceutical residues in a French national water survey","volume":"69","author":"Houeto","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Lee, H., Chae, M., and Lee, S. (2023). Environmental monitoring and risk assessment of pharmaceutical residues discharged from large livestock complex in the Geum River Basin, South Korea. Water, 15.","DOI":"10.3390\/w15223913"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"14223","DOI":"10.1021\/acs.est.2c06088","article-title":"Risk assessment acknowledging variability in both exposure and effect","volume":"56","author":"Hermens","year":"2022","journal-title":"Environ. Sci. Technol."},{"key":"ref_108","first-page":"319","article-title":"Neurotoxicity evaluation of meloxicam in the alternative in vivo model, Caenorhabditis elegans","volume":"8","author":"Bigolin","year":"2020","journal-title":"Int. J. Innov. Educ. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"140043","DOI":"10.1016\/j.scitotenv.2020.140043","article-title":"Toxicity of the non-steroidal anti-inflammatory drugs (NSAIDs) acetylsalicylic acid, paracetamol, diclofenac, ibuprofen and naproxen towards freshwater invertebrates: A review","volume":"740","author":"Parolini","year":"2020","journal-title":"Sci. Total Environ."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/etc.3260","article-title":"Use of acute and chronic ecotoxicity data in environmental risk assessment of pharmaceuticals","volume":"35","author":"Vestel","year":"2016","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"178927","DOI":"10.1016\/j.scitotenv.2025.178927","article-title":"Mechanisms of action and adaptive responses to diclofenac and meloxicam during the early life stages of Oryzias melastigma","volume":"969","author":"Liang","year":"2025","journal-title":"Sci. Total Environ."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/etc.5528","article-title":"Do pharmaceuticals in the environment pose a risk to wildlife?","volume":"43","author":"Bean","year":"2024","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Tiwari, B., Drogui, P., and Tyagi, R. (2020). Removal of emerging micro-pollutants from pharmaceutical industry wastewater. Current Developments in Biotechnology and Bioengineering, Elsevier BV.","DOI":"10.1016\/B978-0-12-819594-9.00018-8"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s41207-023-00422-x","article-title":"Recent advances in the treatment of wastewater contaminated with pharmaceutical pollutants: A critical review","volume":"9","author":"Souabi","year":"2024","journal-title":"Euro-Mediterr. J. Environ. Integr."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"104815","DOI":"10.1016\/j.ultsonch.2019.104815","article-title":"Preparation of zinc tungstate nanomaterial and its sonocatalytic degradation of meloxicam as a novel sonocatalyst in aqueous solution","volume":"61","author":"Xu","year":"2020","journal-title":"Ultrason. Sonochem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"14316","DOI":"10.1007\/s11356-025-36547-5","article-title":"Advanced oxidation process-mediated removal of pharmaceuticals from water: A review of recent advances","volume":"32","author":"Kanakaraju","year":"2025","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"15516","DOI":"10.1007\/s11356-015-4713-2","article-title":"Optimization of photocatalytic degradation of meloxicam using titanium dioxide nanoparticles: Application to pharmaceutical wastewater analysis, treatment, and cleaning validation","volume":"22","author":"Nadim","year":"2015","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"130122","DOI":"10.1016\/j.seppur.2024.130122","article-title":"Synergistic adsorption & photo-Fenton degradation of meloxicam and tetracycline by hollow nanoflower-like S-scheme FeWO4\/ZnIn2S4 heterojunction: Mechanism, toxicity assessment, and potential applications","volume":"357","author":"Zheng","year":"2025","journal-title":"Sep. Purif. Technol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"120050","DOI":"10.1016\/j.desal.2026.120050","article-title":"Controlled in situ semi-conversion strategy for fabricating a \u201cembedded-covering type\u201d FeCo-LDH\/Ag\/MIL-88B Z-scheme heterojunction: Efficient meloxicam removal via adsorption-photodegradation and enhanced antibacterial activity","volume":"628","author":"Lin","year":"2026","journal-title":"Desalination"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1021\/acs.jced.9b00061","article-title":"Core\u2212shell Fe3O4 @MIL-100(Fe) magnetic nanoparticle for effective removal of meloxicam and naproxen in aqueous solution","volume":"64","author":"Liu","year":"2019","journal-title":"J. Chem. Eng. Data"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"112733","DOI":"10.1016\/j.jinorgbio.2024.112733","article-title":"Construction of artificial peroxidase based on myoglobin scaffold for efficient degradation of meloxicam","volume":"262","author":"Zhang","year":"2025","journal-title":"J. Inorg. Biochem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"118385","DOI":"10.1016\/j.jenvman.2023.118385","article-title":"Electrochemical-based approaches for the treatment of pharmaceuticals and personal care products in wastewater","volume":"344","author":"Nagarajan","year":"2023","journal-title":"J. Environ. Manag."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"103977","DOI":"10.1016\/j.jwpe.2023.103977","article-title":"Pharmaceutical waste-water treatment via advanced oxidation based integrated processes: An engineering and economic perspective","volume":"54","author":"Thakur","year":"2023","journal-title":"J. Water Process Eng."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Surra, E., Correia, M., Figueiredo, S., Silva, J.G., Vieira, J., Jorge, S., Pazos, M., \u00c1ngeles Sanrom\u00e1n, M., Lapa, N., and Delerue-Matos, C. (2021). Life cycle and economic analyses of the removal of pesticides and pharmaceuticals from municipal wastewater by anodic oxidation. Sustainability, 13.","DOI":"10.3390\/su13073669"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"132079","DOI":"10.1016\/j.jclepro.2022.132079","article-title":"Insights into current physical, chemical and hybrid technologies used for the treatment of wastewater contaminated with pharmaceuticals","volume":"361","author":"Ghazal","year":"2022","journal-title":"J. Clean. Prod."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"175","DOI":"10.35534\/er.0701013","article-title":"Advances in organic pollutant degradation technologies for pharmaceutical wastewater: Efficiency, mechanistic pathways, and challenges in application","volume":"7","author":"Liu","year":"2025","journal-title":"Environ. Resour."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Miglani, R., Parveen, N., Kumar, A., Ansari, M.A., Khanna, S., Rawat, G., Panda, A.K., Bisht, S.S., Upadhyay, J., and Ansari, M.N. (2022). Degradation of xenobiotic pollutants: An environmentally sustainable approach. Metabolites, 12.","DOI":"10.3390\/metabo12090818"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4014\/jmb.0811.643","article-title":"Studies on microbial transformation of meloxicam by fungi","volume":"19","author":"Prasad","year":"2009","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12088-011-0099-0","article-title":"Biotransformation of meloxicam by Cunninghamella blakesleeana: Significance of carbon and nitrogen source","volume":"51","author":"Prasad","year":"2011","journal-title":"Indian J. Microbiol."},{"key":"ref_130","first-page":"3610","article-title":"Bioconversion of meloxicam by bacteria","volume":"8","author":"Prasad","year":"2009","journal-title":"Afr. J. Biotechnol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"113694","DOI":"10.1016\/j.jenvman.2021.113694","article-title":"A review on environmental occurrence, toxicity and microbial degradation of non-steroidal anti-inflammatory drugs (NSAIDs)","volume":"300","author":"Rastogi","year":"2021","journal-title":"J. Environ. Manag."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1038\/s41598-019-45732-9","article-title":"Features of diclofenac biodegradation by Rhodococcus ruber IEGM 346","volume":"9","author":"Ivshina","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Ivshina, I.B., Tyumina, E.A., Bazhutin, G.A., and Vikhareva, E.V. (2021). Response of Rhodococcus cerastii IEGM 1278 to toxic effects of ibuprofen. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260032"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ecoenv.2018.10.067","article-title":"Ecotoxicology and environmental safety naproxen ecotoxicity and biodegradation by Bacillus thuringiensis B1 (2015b) strain","volume":"167","author":"Guzik","year":"2019","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.watres.2019.05.065","article-title":"Bioremoval of non-steroidal anti-inflammatory drugs by Pseudoxanthomonas sp. DIN-3 isolated from biological activated carbon process","volume":"161","author":"Lu","year":"2019","journal-title":"Water Res."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Marchlewicz, A., Guzik, U., Hupert-Kocurek, K., and Wojcieszy\u0144ska, D. (2023). Evaluation of the defined bacterial consortium efficacy in the biodegradation of NSAIDs. Molecules, 28.","DOI":"10.3390\/molecules28052185"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Cyco\u0144, M., \u017bmijowska, A., and Klim, M. (2025). Enhanced dissipation of non-steroidal anti-inflammatory drugs (NSAIDs) in soil by the bioaugmentation with newly isolated strain Acinetobacter johnsonii MC5. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26010190"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Klim, M., \u017bmijowska, A., and Cyco\u0144, M. (2025). Potential of newly isolated strain Pseudomonas aeruginosa MC-1\/23 for the bioremediation of soil contaminated with selected non-steroidal anti-inflammatory drugs. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1542875"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s13201-023-02064-4","article-title":"Economic evaluation for anoxic biological system integrated with external membrane for pharmaceutical wastewater treatment","volume":"14","author":"Bazedi","year":"2024","journal-title":"Appl. Water Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"11719","DOI":"10.1007\/s13762-023-04867-z","article-title":"Recent advances in the biological treatment of wastewater rich in emerging pollutants produced by pharmaceutical industrial discharges","volume":"20","author":"Madinzi","year":"2023","journal-title":"Int. J. Environ. Sci. Technol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.scitotenv.2015.06.010","article-title":"High sensitive multiresidue analysis of pharmaceuticals and antifungals in surface water using U-HPLC-Q-Exactive Orbitrap HRMS. Application to the Danube river basin on the Romanian territory","volume":"532","author":"Chitescu","year":"2015","journal-title":"Sci. Total Environ."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e39839","DOI":"10.1016\/j.heliyon.2024.e39839","article-title":"Degradation of piroxicam and celecoxib from aqueous solution by high-energy electron beam as a Sustainable method","volume":"10","author":"Yazdi","year":"2024","journal-title":"Heliyon"}],"container-title":["Toxics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2305-6304\/14\/7\/631\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:44:07Z","timestamp":1784720647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2305-6304\/14\/7\/631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":144,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["toxics14070631"],"URL":"https:\/\/doi.org\/10.3390\/toxics14070631","relation":{},"ISSN":["2305-6304"],"issn-type":[{"value":"2305-6304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}